<DOC>
	<DOCNO>NCT03090789</DOCNO>
	<brief_summary>This multicenter natural history study aim expand network clinical research center FA , provide framework facilitate therapeutic intervention . In addition , study lead development valid yet sensitive clinical measure crucial outcome assessment patient Friedreich 's Ataxia . This study support genetic modifier study , biomarker study , frataxin protein level assessment build sample repository .</brief_summary>
	<brief_title>FA Clinical Outcome Measures</brief_title>
	<detailed_description>Friedreich 's ataxia ( FA ) rare autosomal recessive degenerative disorder characterize ataxia , dysarthria , sensory loss , diabetes cardiomyopathy . The discovery abnormal gene FA product ( frataxin ) provide insight possible pathophysiological mechanism novel approach treatment disease . While method assess disease progression may useful , evaluation clinical trial require specific clinical outcome measure . This multicenter natural history study aim expand network clinical research center specialize Friedreich 's Ataxia advance clinical care , research therapeutic approach FA development validation clinical outcome measure . Study sit aim collect quantitative serial clinical data patient FA expand exist research network . In addition , study support various genetic modifier study , biomarker study , frataxin protein level assessment patient FA , carrier , control . This study recruit 1500 patient Friedreich ataxia worldwide , assess annually 15 year . All individual genetic clinical diagnosis FA participate . Study participation involve yearly assessment core set clinical measure quality life assessment measure addition optional collection cheek swab and/or blood sample .</detailed_description>
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Friedreich Ataxia</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<criteria>1 . Males females age 4 80 year . 2 . Genetically confirm diagnosis FA ( carrier/control cheek swab blood sample require ) . 3 . Clinically confirm diagnosis FA , pending confirmatory genetic test commercial research laboratory ( carrier/control cheek swab blood sample require ) . 4 . Parental/guardian permission ( informed consent ) appropriate , child assent . 1 ) Signs symptom severe cardiomyopathy ( congestive heart failure )</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Friedreich Ataxia</keyword>
	<keyword>Neuro-degenerative disease</keyword>
</DOC>